Subscribe
lisa-kolbasa-shutterstock-com
Lisa Kolbasa / Shutterstock.com
19 May 2016AfricaHemant Singh

Patent analysis: CRISPR technology in India

CRISPR is the acronym for ‘clustered regularly interspaced short palindromic repeats’. The technology is a targeted tool used to edit genomes with unparalleled precision, efficiency, and flexibility.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Startups toolkit: Why investors want more than patents
Kilpatrick adds ‘seasoned litigator’ as trademark partner
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler
Bayer, Orion take on Indian generic over $117bn drug
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market